Grace Therapeutics, Inc. Investment Income, Interest
Grace Therapeutics, Inc. (GRCE) reported Investment Income, Interest of $141.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- Grace Therapeutics, Inc. investment income, interest for the quarter ending 2026-06-30 was $141.00K, a 31.22% decline year-over-year.
- Grace Therapeutics, Inc. investment income, interest for the quarter ending 2026-03-31 was $138.00K, a 17.37% decline year-over-year.
- Grace Therapeutics, Inc. investment income, interest for the quarter ending 2025-12-31 was $170.00K, a 23.19% increase year-over-year.
- Grace Therapeutics, Inc. investment income, interest for the quarter ending 2025-09-30 was $172.00K, a 0.00% change year-over-year.
- Grace Therapeutics, Inc. investment income, interest for fiscal 2026 was $685.00K, a 3.66% decline from fiscal 2025.
- Grace Therapeutics, Inc. investment income, interest for fiscal 2025 was $711.00K, a 21.95% decline from fiscal 2024.
- Grace Therapeutics, Inc. investment income, interest for fiscal 2024 was $911.00K, a 270.33% increase from fiscal 2023.
- Grace Therapeutics, Inc. investment income, interest for fiscal 2023 was $246.00K, a 219.48% increase from fiscal 2022.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141.00K 10-Q · filed 2026-08-13 | $279.00K derived: sum of 2 quarters · filed 2026-08-13 | $449.00K derived: sum of 3 quarters · filed 2026-08-13 | $621.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $308.00K derived: sum of 2 quarters · filed 2026-06-18 | $480.00K derived: sum of 3 quarters · filed 2026-06-18 | $685.00K 10-K · filed 2026-06-18 | ||
| 2025-12-31 | $170.00K 10-Q · filed 2026-02-12 | $342.00K derived: sum of 2 quarters · filed 2026-02-12 | $547.00K 10-Q · filed 2026-02-12 | $714.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-09-30 | $172.00K 10-Q · filed 2025-11-13 | $375.00K 10-Q · filed 2025-11-13 | $544.00K derived: sum of 3 quarters · filed 2026-08-13 | $682.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $205.00K 10-Q · filed 2026-08-13 | $372.00K derived: sum of 2 quarters · filed 2026-08-13 | $510.00K derived: sum of 3 quarters · filed 2026-08-13 | $682.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $305.00K derived: sum of 2 quarters · filed 2026-06-18 | $477.00K derived: sum of 3 quarters · filed 2026-06-18 | $711.00K 10-K · filed 2026-06-18 | ||
| 2024-12-31 | $138.00K 10-Q · filed 2026-02-12 | $310.00K derived: sum of 2 quarters · filed 2026-02-12 | $544.00K 10-Q · filed 2026-02-12 | $794.00K derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-09-30 | $172.00K 10-Q · filed 2025-11-13 | $407.00K 10-Q · filed 2025-11-13 | $656.00K derived: sum of 3 quarters · filed 2025-11-13 | $972.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $235.00K 10-Q · filed 2025-08-12 | $484.00K derived: sum of 2 quarters · filed 2025-08-12 | $800.00K derived: sum of 3 quarters · filed 2025-08-12 | $1.01M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | $565.00K derived: sum of 2 quarters · filed 2025-06-23 | $777.00K derived: sum of 3 quarters · filed 2025-06-23 | $911.00K 10-K · filed 2025-06-23 | ||
| 2023-12-31 | $316.00K 10-Q · filed 2025-02-13 | $528.00K derived: sum of 2 quarters · filed 2025-02-13 | $662.00K 10-Q · filed 2025-02-13 | $774.00K derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-09-30 | $212.00K 10-Q · filed 2024-11-13 | $346.00K 10-Q · filed 2024-11-13 | $458.00K derived: sum of 3 quarters · filed 2024-11-13 | $525.00K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $134.00K 10-Q · filed 2024-08-09 | $246.00K derived: sum of 2 quarters · filed 2024-08-09 | $313.00K derived: sum of 3 quarters · filed 2024-08-09 | $349.00K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $179.00K derived: sum of 2 quarters · filed 2024-06-21 | $215.00K derived: sum of 3 quarters · filed 2024-06-21 | $246.00K 10-K · filed 2024-06-21 | ||
| 2022-12-31 | $67.00K 10-Q · filed 2024-02-12 | $64.00K 10-Q · filed 2023-02-14 | $103.00K derived: sum of 2 quarters · filed 2024-02-12 | $134.00K 10-Q · filed 2024-02-12 | $59.00K 10-Q · filed 2023-02-14 | $21.00K derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | $36.00K 10-Q · filed 2023-11-13 | $68.00K 10-Q · filed 2023-11-13 | -$46.00K derived: sum of 3 quarters · filed 2023-11-13 | -$6.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $32.00K 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2022-08-11 | -$82.00K derived: sum of 2 quarters · filed 2023-08-11 | -$42.00K derived: sum of 3 quarters · filed 2023-08-11 | -$28.00K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | -$74.00K derived: sum of 2 quarters · filed 2023-06-23 | -$60.00K derived: sum of 3 quarters · filed 2023-06-23 | $77.00K 10-K · filed 2023-06-23 | ||
| 2021-12-31 | $40.00K 10-Q · filed 2023-02-14 | $54.00K derived: sum of 2 quarters · filed 2023-02-14 | $191.00K 10-Q · filed 2023-02-14 | $104.00K derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-09-30 | $14.00K 10-Q · filed 2022-11-14 | $151.00K 10-Q · filed 2022-11-14 | $64.00K derived: sum of 3 quarters · filed 2022-11-14 | $102.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $20.00K 10-Q · filed 2022-08-11 | $139.00K 10-Q · filed 2021-08-12 | $50.00K derived: sum of 2 quarters · filed 2022-08-11 | $88.00K derived: sum of 3 quarters · filed 2022-08-11 | $103.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | $68.00K derived: sum of 2 quarters · filed 2022-06-21 | $83.00K derived: sum of 3 quarters · filed 2022-06-21 | $107.00K 10-K · filed 2022-06-21 | ||
| 2020-12-31 | $38.00K 10-Q · filed 2022-02-14 | $53.00K derived: sum of 2 quarters · filed 2022-02-14 | $77.00K 10-Q · filed 2022-02-14 | $139.00K derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | $15.00K 10-Q · filed 2021-11-10 | $39.00K 10-Q · filed 2021-11-10 | $101.00K derived: sum of 3 quarters · filed 2021-11-10 | $147.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $25.00K 10-Q · filed 2021-08-12 | $86.00K derived: sum of 2 quarters · filed 2021-08-12 | $132.00K derived: sum of 3 quarters · filed 2021-08-12 | $257.00K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-22 | $107.00K derived: sum of 2 quarters · filed 2021-06-22 | $232.00K derived: sum of 3 quarters · filed 2021-06-22 | $336.00K 10-K · filed 2021-06-22 | ||
| 2019-12-31 | $46.00K 10-Q · filed 2021-02-09 | $171.00K derived: sum of 2 quarters · filed 2021-02-09 | $275.00K 10-Q · filed 2021-02-09 | |||
| 2019-09-30 | $125.00K 10-Q · filed 2020-11-16 | $228.00K 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $103.00K 10-Q · filed 2020-08-13 | |||||
| 2019-03-31 | $358.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |